{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:12:18Z","timestamp":1776395538331,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS106313"],"award-info":[{"award-number":["R21NS106313"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG055545"],"award-info":[{"award-number":["R01AG055545"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG051501"],"award-info":[{"award-number":["R56AG051501"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.nbd.2021.105583","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:35:05Z","timestamp":1639182905000},"page":"105583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice"],"prefix":"10.1016","volume":"162","author":[{"given":"Ryan","family":"Massopust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin","family":"Juros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dillon","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikayla","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saptarsi M.","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Taetzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorio","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105583_bb0005","first-page":"51303","article-title":"Assessing functional performance in the Mdx mouse model","volume":"85","author":"Aartsma-Rus","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2021.105583_bb0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41434-020-0146-8","article-title":"Muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice","volume":"27","author":"Ahlskog","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2021.105583_bb0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jamda.2016.04.019","article-title":"Skeletal muscle regulates metabolism via Interorgan crosstalk: roles in health and disease","volume":"17","author":"Argil\u00e9s","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.nbd.2021.105583_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/21678421.2013.764568","article-title":"Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS","volume":"14","author":"Beghi","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.nbd.2021.105583_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","article-title":"Skeletal muscle is a primary target of SOD1G93A-mediated toxicity","volume":"8","author":"Dobrowolny","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2021.105583_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.00831","article-title":"Metabolic changes associated with muscle expression of SOD1G93A","volume":"9","author":"Dobrowolny","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.nbd.2021.105583_bb0035","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1073\/pnas.0402026101","article-title":"Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model","volume":"101","author":"Dupuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105583_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2005.07.020","article-title":"Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man","volume":"198","author":"Echaniz-Laguna","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105583_bb0045","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139496","article-title":"Muscle Kr\u00fcppel-like factor 15 regulates lipid flux and systemic metabolic homeostasis","volume":"131","author":"Fan","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2021.105583_bb0050","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1194\/jlr.M700017-JLR200","article-title":"Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis","volume":"48","author":"Fergani","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2021.105583_bb0055","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105583_bb0060","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science."},{"key":"10.1016\/j.nbd.2021.105583_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2007.04.005","article-title":"Kruppel-like factors (KLFs) in muscle biology","volume":"43","author":"Haldar","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.nbd.2021.105583_bb0070","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1073\/pnas.1121060109","article-title":"Kruppel-like factor 15 regulates skeletal muscle lipid flux and exercise adaptation","volume":"109","author":"Haldar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105583_bb0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2007.07.003","article-title":"Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"28","author":"Hegedus","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105583_bb0080","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1113\/jphysiol.2007.149286","article-title":"Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"586","author":"Hegedus","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2021.105583_bb0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/mus.880170708","article-title":"Decremental motor responses to repetitive nerve stimulation in ALS","volume":"17","author":"Killian","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2021.105583_bb0090","article-title":"Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105583_bb0095","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","article-title":"Gains, losses, and implications for future therapies","volume":"108","author":"Kim","year":"2020","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2021.105583_bb0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brainres.2005.11.052","article-title":"L-Carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis","volume":"1070","author":"Kira","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2021.105583_bb0105","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/brain\/awh540","article-title":"Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies","volume":"128","author":"Krasnianski","year":"2005","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2021.105583_bb0110","series-title":"Brain Pathol","first-page":"227","article-title":"The role of skeletal muscle in amyotrophic lateral sclerosis","author":"Loeffler","year":"2016"},{"key":"10.1016\/j.nbd.2021.105583_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.25661","article-title":"Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis","volume":"87","author":"Ludolph","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105583_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.expneurol.2011.05.007","article-title":"Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study","volume":"231","author":"Marcuzzo","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105583_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.592851","article-title":"Skeletal muscle-restricted expression of human SOD1 in transgenic mice causes a fatal ALS-like syndrome","volume":"11","author":"Martin","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2021.105583_bb0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2014.00252","article-title":"ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease","volume":"8","author":"Moloney","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2021.105583_bb0135","doi-asserted-by":"crossref","first-page":"E6780","DOI":"10.1073\/pnas.1512968112","article-title":"Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program","volume":"112","author":"Morrison-Nozik","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105583_bb0140","series-title":"Unbiased Stereology\u202f: A Concise Guide \/","author":"Mouton","year":"2011"},{"key":"10.1016\/j.nbd.2021.105583_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/01913120252934260","article-title":"Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis","volume":"26","author":"Myoung","year":"2002","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.nbd.2021.105583_bb0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/21678421.2012.735240","article-title":"Premorbid body mass index and risk of amyotrophic lateral sclerosis","volume":"14","author":"O\u2019Reilly","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.nbd.2021.105583_bb0155","doi-asserted-by":"crossref","first-page":"526","DOI":"10.15252\/emmm.201404433","article-title":"A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Palamiuc","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2021.105583_bb0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nn1653","article-title":"Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF","volume":"9","author":"Pun","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2021.105583_bb0165","article-title":"Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis","volume":"2","author":"Steyn","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2021.105583_bb0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1523\/JNEUROSCI.2992-16.2016","article-title":"Muscle fibers secrete FGFBP1 to slow degeneration of neuromuscular synapses during aging and progression of ALS","volume":"37","author":"Taetzsch","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105583_bb0175","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1152\/physrev.00033.2014","article-title":"Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting","volume":"95","author":"Tintignac","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2021.105583_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034640","article-title":"Shared resistance to aging and ALS in neuromuscular junctions of specific muscles","volume":"7","author":"Valdez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105583_bb0185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","article-title":"Energy metabolism in ALS: an underappreciated opportunity?","volume":"135","author":"Vandoorne","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2021.105583_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(99)00236-1","article-title":"Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis","volume":"169","author":"Vielhaber","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2021.105583_bb0195","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ebiom.2018.04.024","article-title":"Interventions targeting glucocorticoid-Kr\u00fcppel-like factor 15-branched-chain amino acid signaling improve disease phenotypes in spinal muscular atrophy mice","volume":"31","author":"Walter","year":"2018","journal-title":"EBioMedicine."},{"key":"10.1016\/j.nbd.2021.105583_bb0200","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/hmg\/ddq106","article-title":"Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice","volume":"19","author":"Wong","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105583_bb0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3988\/jcn.2013.9.2.125","article-title":"Hypolipidemia in patients with amyotrophic lateral sclerosis: a possible gender difference?","volume":"9","author":"Yang","year":"2013","journal-title":"J. Clin. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121003326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121003326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:31:31Z","timestamp":1760851891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121003326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S0969996121003326"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105583","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105583"}}